[1]
Dr. B. Srilatha and Dr. Uday Kumar M 2025. COMPARATIVE STUDY OF EFFICACY AND SAFETY OF SAROGLITAZAR AND FENOFIBRATE IN DIABETIC DYSLIPIDEMIC PATIENTS. Journal of Population Therapeutics and Clinical Pharmacology. 32, 1 (Jan. 2025), 115–119. DOI:https://doi.org/10.53555/kmjv5r69.